NUCLEAR MEDICINE TOMORROW : Dialogue between key opinion leaders : Nuclear Medicine answers Oncology, Cardiology and Neurology challenges
The launching of ARRONAX, the high energy/high intensity cyclotron devoted to the production of innovative radionuclides for Nuclear Medicine in Nantes seemed the perfect opportunity to debate the future of nuclear medicine. The International Symposium « Nuclear Medicine Tomorrow » will be held in Nantes, France, March 30th to April 2nd 2008.
The premise of this symposium is to anticipate the new advances in Nuclear Medicine for the next 10 years by creating a dialogue between key personalities in cardiology, neurology, oncology and specialists in nuclear medicine. The symposium will consist of 5 half-day sessions (1 in cardiology, 1 in neurology and 3 in oncology) with 3 or 4 topics per session. For each topic a clinician will expose his expectations of nuclear medicine for the next 10 years ; followed by a nuclear medicine physician who will analyze the realistic possibilities of succeeding.
A dialogue of this type fully enters Nuclear Medicine’s rapidly advancing development, for, on the one hand, diagnostic applications (PET) in oncology, cardiology and neurology and, on the other hand, for therapy (targeted radionuclide therapy) in oncology.
This symposium should be of high interest to oncologists, neurologists, cardiologists, and nuclear medicine specialists as well as to health professionals, teachers or researchers looking to anticipate the future progress in PET imaging and targeted radiotherapy.